Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Capital Employed (2020 - 2025)

Harmony Biosciences Holdings' Return on Capital Employed history spans 6 years, with the latest figure at 0.21% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 3.0% year-over-year to 0.21%; the TTM value through Dec 2025 reached 0.21%, down 3.0%, while the annual FY2025 figure was 0.24%, 3.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.21% at Harmony Biosciences Holdings, down from 0.24% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.3% in Q4 2023 and bottomed at 0.11% in Q1 2021.
  • The 5-year median for Return on Capital Employed is 0.24% (2025), against an average of 0.23%.
  • The largest annual shift saw Return on Capital Employed rose 18bps in 2021 before it decreased -7bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.24% in 2021, then fell by -15bps to 0.21% in 2022, then soared by 47bps to 0.3% in 2023, then dropped by -21bps to 0.24% in 2024, then decreased by -13bps to 0.21% in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Return on Capital Employed are 0.21% (Q4 2025), 0.24% (Q3 2025), and 0.25% (Q2 2025).